| Literature DB >> 34222400 |
Hiroshi Asakura1, Tatsuya Nakayama1, Shiori Yamamoto1, Kazuki Izawa2, Jun Kawase3, Yasushi Torii4, Satoshi Murakami4.
Abstract
Campylobacter jejuni is one of the leading causes of gastrointestinal illness worldwide and is mainly transmitted from chicken through the food chain. Previous studies have provided increasing evidence that this pathogen can colonize and replicate in broiler chicken during its breeding; however, its temporal kinetics in laying hen are poorly understood. Considering the possible interaction between C. jejuni and gut microbiota, the current study was conducted to address the temporal dynamics of C. jejuni in the cecum of laying hen over 40 weeks, with possible alteration of the gut microbiota and fatty acid (FA) components. Following oral infection with C. jejuni 81-176, inocula were stably recovered from ceca for up to 8 weeks post-infection (p.i.). From 16 weeks p.i., most birds became negative for C. jejuni and remained negative up to 40 weeks p.i. 16S rRNA gene sequencing analyses revealed that most of the altered relative rRNA gene abundances occurred in the order Clostridiales, in which increased relative rRNA gene abundances were observed at >16 weeks p.i. in the families Clostridiaceae, Ruminococcaceae, Lachnospiraceae, and Peptococcaceae. Lipidome analyses revealed increased levels of sterols associated with bile acid metabolisms in the cecum at 16 and/or 24 weeks p.i. compared with those detected at 8 weeks p.i., suggesting that altered microbiota and bile acid metabolism might underlie the decreased colonization fitness of C. jejuni in the gut of laying hens.Entities:
Keywords: Campylobacter jejuni; gut microbiota; laying hen; lipidome; long-term breeding
Year: 2021 PMID: 34222400 PMCID: PMC8249580 DOI: 10.3389/fvets.2021.675570
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Figure 1Temporal colonization fitness of C. jejuni 81-176 in the caecum of laying hens. Each dot (gray) represents bacterial numbers detected per a gram of caecum. Dotted line represents median at each sampling time point. Statistical significance of the differences in the number of bacteria between the groups (2 and 8 weeks p.i. vs. 16–40 weeks p.i.) by Fisher's extract test.
Figure 2Altered microbiome in the caecum of laying hens during infection experiments. (A) Time-dependent dynamics of representative bacterial phylum as detected in caecal samples of laying hens. (B) Time-dependent dynamics of the Firmicutes/Bacteroidetes (F/B) ratio of the caecal microbiomes. (C) Time-dependent dynamics of representative bacterial family as detected in caecal samples of laying hens. (D) Time-dependent dynamics of representative bacterial genera as detected in caecal samples of laying hens. (E) Principle coordinate analysis (PCoA) plot of representative bacterial phylum as detected in caecal samples of laying hens. Dots are shown in different colors by time points (0 weeks p.i., orange; 2 weeks and 8 weeks p.i., blue; >16 weeks p.i., green). (F) Fold changes in the relative abundances of representative bacterial genera between >16 weeks p.i. and <8 weeks p.i. Bacterial genera exhibiting the increased relative abundance at >16 weeks p.i. compared with 2/8 weeks p.i. are shown with green color, and those exhibiting the decreased relative abundances at >16 weeks p.i. compared with 2/8 weeks p.i. are shown with red color, respectively.
Relative abundance of bacterial genera (%) in the cecum of laying hens.
| 3.91 ± 0.80 | 3.61 ± 0.37 | 1.0000 | 6.96 ± 1.04 | |||
| 0.49 ± 0.35 | 0.58 ± 0.40 | 1.0000 | 3.66 ± 0.96 | |||
| 0.83 ± 0.18 | 1.22 ± 0.26 | 1.0000 | 2.37 ± 0.40 | |||
| 0.89 ± 0.16 | 0.86 ± 0.13 | 1.0000 | 1.62 ± 0.21 | |||
| 0.79 ± 0.13 | 0.89 ± 0.23 | 1.0000 | 1.44 ± 0.34 | |||
| 1.08 ± 0.19 | 0.91 ± 0.17 | 0.8886 | 1.27 ± 0.25 | 0.9690 | ||
| 0.64 ± 0.09 | 0.76 ± 0.12 | 1.0000 | 1.11 ± 0.21 | |||
| 0.53 ± 0.16 | 0.62 ± 0.16 | 1.0000 | 1.14 ± 0.35 | |||
| 0.41 ± 0.08 | 0.39 ± 0.10 | 1.0000 | 1.03 ± 0.14 | |||
| 0.40 ± 0.18 | 0.42 ± 0.06 | 1.0000 | 0.84 ± 0.17 | |||
| 0.16 ± 0.03 | 0.21 ± 0.08 | 1.0000 | 0.85 ± 0.29 | |||
| 0.15 ± 0.02 | 0.37 ± 0.31 | 1.0000 | 0.76 ± 0.13 | |||
| 7.65 ± 0.13 | 8.30 ± 1.01 | 1.0000 | 6.33 ± 0.68 | 0.0989 | ||
| 4.37 ± 3.03 | 8.98 ± 4.25 | 0.5700 | 2.81 ± 1.43 | 1.0000 | ||
| 6.46 ± 1.10 | 5.57 ± 1.21 | 1.0000 | 3.86 ± 0.87 | |||
| 4.19 ± 2.19 | 5.76 ± 1.30 | 0.4308 | 3.54 ± 1.16 | 1.0000 | ||
| 3.60 ± 0.39 | 3.78 ± 0.54 | 1.0000 | 2.89 ± 0.41 | 0.1791 | ||
| 2.31 ± 0.40 | 2.39 ± 0.39 | 1.0000 | 1.63 ± 0.24 | 0.0939 | ||
| 2.30 ± 0.66 | 2.18 ± 0.34 | 1.0000 | 1.64 ± 0.26 | 0.1408 | ||
| 1.24 ± 0.30 | 1.00 ± 0.16 | 1.0000 | 0.45 ± 0.08 | |||
| 1.24 ± 0.32 | 0.79 ± 0.26 | 1.0000 | 0.25 ± 0.06 | |||
Bacterial genera exhibiting >0.50% of relative abundance on average in total are listed. p.i., post-infection.
P-values were calculated using a non-parametric joint ranked Dunn test.
Bold values represent P-values of <0.05.
Figure 3Cytokine production in the sera of laying hens after experimental C. jejuni infection.
Summary of altered lipids in the gut of laying hens between 8, 16, and 24 weeks p.i.
| Fatty acid metabolite | FA (27:1) | 21 | 2,905 | 11,031 | 12,297.5 | 0.123 | 0.594 | |
| FA (28:0) | 64 | 1,220.5 | 4,682.5 | 4,289.5 | 0.186 | |||
| AAHFA (5:0/26:0) | 59 | 560.5 | 2,532.5 | 4,867 | 0.426 | 0.371 | ||
| AH2FA (4:0/25:0) | 22 | 713.5 | 1,605 | 2,449 | 0.411 | 0.432 | ||
| CmpE (26:0) | 53 | 335.5 | 1,167 | 1,462 | 0.249 | 0.549 | ||
| Glycerolipid | TG (45:1) | 203 | 336.5 | 800 | 798.5 | 0.370 | 0.997 | |
| MGDG (18:0/20:2) | 11 | 439 | 1,652.5 | 596 | 0.316 | |||
| Phospholipid | MLCL (16:0/16:0/18:2) | 0 | 237 | 892.5 | 452.5 | 0.069 | ||
| CL (e/e)(28:1e/30:1e) | 11 | 2,024.5 | 2,591.5 | 5,378.5 | 0.568 | 0.099 | ||
| CL (e/e)(30:1e/33:3e) | 0 | 1,178.5 | 1,298.5 | 2,452.5 | 0.835 | 0.222 | ||
| CL (30:1e/30:3e) | 0 | 125 | 219 | 296.5 | 0.140 | 0.198 | ||
| DLCL (16:0/16:0) | 16 | 3,637.5 | 17,440 | 10,366 | 0.175 | 0.327 | ||
| DLCL (16:0/18:2) | 0 | 1,853 | 5,436 | 2,487 | 0.628 | 0.200 | ||
| HBMP (18:0/18:1/g18:1) | 11 | 100 | 237 | 331.5 | 0.240 | 0.496 | ||
| HBMP (14:0/16:0/18:0) | 0 | 158.5 | 341.5 | 424.5 | 0.081 | 0.289 | ||
| PG (18:2/18:2) | 16 | 1,353.5 | 2,083.5 | 2,179 | 0.620 | 0.950 | ||
| Sphingolipid | CerPI (d44:0) | 0 | 158 | 700.5 | 990 | 0.060 | ||
| AcylCerPG (t18:0/16:0/15:0) | 0 | 361 | 2,758.5 | 2,101 | 0.052 | 0.324 | ||
| Sterol lipids | StE (18:1) | 930 | 50,481.5 | 79,812.5 | 118,907.5 | 0.286 | 0.200 | |
| StE (18:0) | 236 | 4,940 | 9,740.5 | 11,280 | 0.298 | 0.646 | ||
| SISL G1 | 157 | 30,164.5 | 64,382 | 49,213 | 0.067 | 0.181 | ||
| Stigmasterol G1 | 91 | 5,295 | 8,517 | 7,433 | 0.275 | 0.603 | ||
| Fatty acid metabolite | FA (17:0) | 2,265 | 1,335,104 | 909,822.5 | 368,852.5 | 0.619 | 0.543 | |
| FA (18:0) | 151,628 | 6,089,247 | 4,739,226.5 | 2,362,394.5 | 0.711 | 0.546 | ||
| FA (19:1) | 0 | 555,886 | 95,071.5 | 64,656.5 | 0.018 | 0.246 | ||
| FA (20:3) | 23 | 10,567.5 | 2,823.5 | 2,095 | 0.123 | 0.717 | ||
| FA (24:1) | 348 | 246,110.5 | 127,115 | 94,823.5 | 0.088 | 0.309 | ||
| FA (24:2) | 35 | 21,430 | 13,737.5 | 12,986 | 0.298 | 0.887 | ||
| FA(O) (18:0) | 67 | 93,970 | 20,635 | 16,832 | 0.067 | 0.862 | ||
| FA(aOH)(16:0) | 164 | 1,059,824.5 | 315,401 | 86,486 | 0.173 | 0.135 | ||
| FA(aOH)(18:0) | 241 | 270,228 | 175,671 | 65,140.5 | 0.098 | |||
| FA(aOH)(19:0) | 40 | 29,623.5 | 23,000 | 12,582.5 | 0.120 | 0.059 | ||
| FA(aOH)(22:1) | 21 | 35,900.5 | 22,324.5 | 20,211.5 | 0.061 | 0.252 | ||
| FA(aOH)(24:1) | 66 | 389,587.5 | 212,609.5 | 181,281 | 0.060 | 0.515 | ||
| Glycerolipid | MGDG(sn2+O)(16:0/16:0) | 44 | 24,594.5 | 8,656.5 | 11,126 | 0.301 | ||
| AMGDGM(e) (16:1e/17:0/18:1) | 0 | 1,169.5 | 467 | 344.5 | 0.146 | |||
| AMGDG(e)(18:1e/14:0/18:1) | 0 | 972.5 | 538.5 | 417.5 | 0.244 | |||
| GPMGDG(e)(34:1e) | 34 | 23,957 | 11,863.5 | 10,900 | 0.189 | 0.870 | ||
| GPMGDG(e)(34:3e) | 75 | 5,551 | 3,790 | 4,866 | 0.768 | 0.655 | ||
| DGDG(16:0/18:2) | 21 | 1,161 | 1,267 | 728.5 | 0.705 | 0.228 | ||
| DGDG(18:0/18:1) | 0 | 643.5 | 442 | 308 | 0.421 | 0.554 | ||
| DGDG(e)(18:1e/18:1) | 0 | 6,650 | 2,918 | 1,610 | 0.244 | 0.563 | ||
| DGDG(e)(17:1e/18:1) | 0 | 712.5 | 337.5 | 170.5 | 0.172 | 0.391 | ||
| ADGDG(16:0/18:1/g16:0) | 0 | 746.5 | 630 | 415.5 | 0.457 | 0.255 | ||
| TG(51:4) | 51 | 3,101 | 4,343.5 | 1,829 | 0.702 | 0.492 | ||
| TG(60:4) | 0 | 1,959 | 1,898.5 | 1,046 | 0.934 | 0.372 | ||
| DG (16:0/19:1) | 338 | 68,852.5 | 38,753.5 | 31,749 | 0.117 | 0.571 | ||
| Phospholipid | PE(16:0/16:1) | 11 | 364.5 | 262.5 | 765.5 | 0.531 | 0.459 | |
| Lyso PC (20:0) | 190 | 2,531.5 | 2,373.5 | 427 | 0.893 | 0.284 | ||
| PE (18:0) | 134 | 1,619.5 | 1,485 | 373 | 0.844 | 0.286 | ||
| Sphingolipid | AcylCer(phyto_aOH)(t18:1/24:0/2:0) | 0 | 4,412.5 | 2,732 | 708.5 | 0.281 | 0.226 | |
| 3-O-AcylSM (d36:1/16:0) | 0 | 579 | 427 | 188 | 0.210 | 0.082 | ||
| Sterol lipid | Taurin (19:1) | 16 | 962.5 | 532.5 | 157.5 | 0.133 | ||
| dehydro cholesterol | 856 | 2,425.5 | 3,853.5 | 1,408.5 | 0.212 | 0.127 | ||
| Prenol lipid | Coenzyme Q9H2 | 155 | 78,620.5 | 11,985.5 | 14,275.5 | 0.747 | ||
| Coenzyme Q11 | 88 | 17,740 | 7,237.5 | 3,685 | 0.089 | 0.299 | ||
| Coenzyme Q11H2 | 0 | 3,928.5 | 952.5 | 757.5 | 0.077 | 0.805 | ||
| Others | Tocopherol | 76 | 16,937 | 6,859.5 | 5,661.5 | 0.459 | ||
p.i., post-infection.
*1 The abbreviation of each lipid component is defined in .
*2 P < 0.05, indicated in bold.